Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.

Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ.

Dev Cell. 2008 Jun;14(6):926-39. doi: 10.1016/j.devcel.2008.04.003.

2.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
3.

Fragile X syndrome: From protein function to therapy.

Bagni C, Oostra BA.

Am J Med Genet A. 2013 Nov;161A(11):2809-21. doi: 10.1002/ajmg.a.36241. Epub 2013 Sep 24. Review.

PMID:
24115651
4.

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Bassell GJ, Warren ST.

Neuron. 2008 Oct 23;60(2):201-14. doi: 10.1016/j.neuron.2008.10.004. Review.

5.

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Ronesi JA, Huber KM.

Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Review.

PMID:
18272470
6.

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Santoro MR, Bray SM, Warren ST.

Annu Rev Pathol. 2012;7:219-45. doi: 10.1146/annurev-pathol-011811-132457. Epub 2011 Oct 10. Review.

PMID:
22017584
7.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Review.

PMID:
23727436
8.

The translation of translational control by FMRP: therapeutic targets for FXS.

Darnell JC, Klann E.

Nat Neurosci. 2013 Nov;16(11):1530-6. doi: 10.1038/nn.3379. Epub 2013 Apr 14. Review.

9.

The state of synapses in fragile X syndrome.

Pfeiffer BE, Huber KM.

Neuroscientist. 2009 Oct;15(5):549-67. doi: 10.1177/1073858409333075. Epub 2009 Mar 26. Review.

10.

Fragile X syndrome: Are signaling lipids the missing culprits?

Tabet R, Vitale N, Moine H.

Biochimie. 2016 Nov;130:188-194. doi: 10.1016/j.biochi.2016.09.002. Epub 2016 Sep 3. Review.

PMID:
27597551
11.
12.

Fragile X mental retardation protein: past, present and future.

Kim M, Ceman S.

Curr Protein Pept Sci. 2012 Jun;13(4):358-71. Review.

PMID:
22708486
13.
14.

The fragile X-cerebellum connection.

Huber KM.

Trends Neurosci. 2006 Apr;29(4):183-5. Epub 2006 Feb 28. Review.

PMID:
16500716
15.

Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome.

Beckel-Mitchener A, Greenough WT.

Ment Retard Dev Disabil Res Rev. 2004;10(1):53-9. Review.

PMID:
14994289
16.

Translational endpoints in fragile X syndrome.

de Esch CE, Zeidler S, Willemsen R.

Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:256-69. doi: 10.1016/j.neubiorev.2013.10.012. Epub 2013 Oct 30. Review.

PMID:
24184744
17.

Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface.

Antar LN, Bassell GJ.

Neuron. 2003 Feb 20;37(4):555-8. Review.

18.

The fragile X syndrome: from molecular genetics to neurobiology.

Willemsen R, Oostra BA, Bassell GJ, Dictenberg J.

Ment Retard Dev Disabil Res Rev. 2004;10(1):60-7. Review.

PMID:
14994290
19.

Synaptic regulation of protein synthesis and the fragile X protein.

Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7101-6. Review.

20.

The role of fragile X mental retardation protein in major mental disorders.

Fatemi SH, Folsom TD.

Neuropharmacology. 2011 Jun;60(7-8):1221-6. doi: 10.1016/j.neuropharm.2010.11.011. Epub 2010 Nov 22. Review.

Supplemental Content

Support Center